The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

The Southwest Nebraska Public Health Department (SWNPHD) is urging residents to get vaccinated against Respiratory Syncytial Virus (RSV) and Influenza (flu) as respiratory virus season approaches.

The Centers for Medicare & Medicaid Services snuck new flu, RSV and COVID data-reporting requirements for nursing homes into ...

Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...

The National Advisory Committee on Immunization (NACI) recommends vaccination against RSV for people in Canada aged 75 years ...

Doctors are seeing more patients with respiratory virus symptoms, and the situation isn't likely to improve with the holidays ...

Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...

Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...

RESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose ...